Financhill
Buy
57

CTEV Quote, Financials, Valuation and Earnings

Last price:
$37.23
Seasonality move :
-17.39%
Day range:
$36.42 - $38.12
52-week range:
$4.80 - $40.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.65x
P/B ratio:
41.14x
Volume:
47.7K
Avg. volume:
91.4K
1-year change:
108.3%
Market cap:
$610M
Revenue:
$930.6M
EPS (TTM):
-$72.72

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CTEV
Claritev
$232M -$2.20 -1.76% -93.41% $34.50
DRIO
DarioHealth
$8.5M -$0.06 10.39% -29.16% $2.38
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$4.1M -- -13% -- $4.00
SPOK
Spok Holdings
$35.1M $0.24 3% 18.18% $20.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CTEV
Claritev
$37.11 $34.50 $610M -- $0.00 0% 0.65x
DRIO
DarioHealth
$0.67 $2.38 $29.3M -- $0.00 0% 0.99x
FOXO
FOXO Technologies
$0.22 -- $1.4M -- $0.00 0% 0.06x
OTRK
Ontrak
$1.43 $4.00 $6M -- $0.00 0% 0.70x
SPOK
Spok Holdings
$16.30 $20.00 $335.3M 20.90x $0.31 7.67% 2.41x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CTEV
Claritev
99.68% -1.341 1360.84% 0.77x
DRIO
DarioHealth
28.37% -0.791 111.66% 1.76x
FOXO
FOXO Technologies
38.2% 11.399 144.44% 0.09x
OTRK
Ontrak
67.21% -0.005 155.76% 0.50x
SPOK
Spok Holdings
-- 0.936 -- 0.99x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CTEV
Claritev
$170.9M $9.7M -23.75% -283.02% 0.76% -$68.9M
DRIO
DarioHealth
$3.9M -$9.4M -45.31% -63.94% -139.35% -$6.7M
FOXO
FOXO Technologies
$1.3M -$1.5M -214.25% -- 8.49% -$1.3M
OTRK
Ontrak
$746K -$5.9M -144.37% -222.91% -290.04% -$2.8M
SPOK
Spok Holdings
$29.1M $6.1M 10.19% 10.19% 16.74% $1.5M

Claritev vs. Competitors

  • Which has Higher Returns CTEV or DRIO?

    DarioHealth has a net margin of -30.83% compared to Claritev's net margin of -136.66%. Claritev's return on equity of -283.02% beat DarioHealth's return on equity of -63.94%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    DRIO
    DarioHealth
    57.49% -$0.14 $102.9M
  • What do Analysts Say About CTEV or DRIO?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -7.03%. On the other hand DarioHealth has an analysts' consensus of $2.38 which suggests that it could grow by 256.61%. Given that DarioHealth has higher upside potential than Claritev, analysts believe DarioHealth is more attractive than Claritev.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    DRIO
    DarioHealth
    3 1 0
  • Is CTEV or DRIO More Risky?

    Claritev has a beta of 0.515, which suggesting that the stock is 48.504% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.583, suggesting its more volatile than the S&P 500 by 58.337%.

  • Which is a Better Dividend Stock CTEV or DRIO?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or DRIO?

    Claritev quarterly revenues are $231.3M, which are larger than DarioHealth quarterly revenues of $6.8M. Claritev's net income of -$71.3M is lower than DarioHealth's net income of -$9.2M. Notably, Claritev's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.65x versus 0.99x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.65x -- $231.3M -$71.3M
    DRIO
    DarioHealth
    0.99x -- $6.8M -$9.2M
  • Which has Higher Returns CTEV or FOXO?

    FOXO Technologies has a net margin of -30.83% compared to Claritev's net margin of -19.45%. Claritev's return on equity of -283.02% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    FOXO
    FOXO Technologies
    39.94% -$0.37 $15.7M
  • What do Analysts Say About CTEV or FOXO?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -7.03%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Claritev has higher upside potential than FOXO Technologies, analysts believe Claritev is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is CTEV or FOXO More Risky?

    Claritev has a beta of 0.515, which suggesting that the stock is 48.504% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CTEV or FOXO?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or FOXO?

    Claritev quarterly revenues are $231.3M, which are larger than FOXO Technologies quarterly revenues of $3.2M. Claritev's net income of -$71.3M is lower than FOXO Technologies's net income of -$616.5K. Notably, Claritev's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.65x versus 0.06x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.65x -- $231.3M -$71.3M
    FOXO
    FOXO Technologies
    0.06x -- $3.2M -$616.5K
  • Which has Higher Returns CTEV or OTRK?

    Ontrak has a net margin of -30.83% compared to Claritev's net margin of -341.65%. Claritev's return on equity of -283.02% beat Ontrak's return on equity of -222.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    OTRK
    Ontrak
    36.99% -$1.65 $14.2M
  • What do Analysts Say About CTEV or OTRK?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -7.03%. On the other hand Ontrak has an analysts' consensus of $4.00 which suggests that it could grow by 179.72%. Given that Ontrak has higher upside potential than Claritev, analysts believe Ontrak is more attractive than Claritev.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    OTRK
    Ontrak
    0 0 0
  • Is CTEV or OTRK More Risky?

    Claritev has a beta of 0.515, which suggesting that the stock is 48.504% less volatile than S&P 500. In comparison Ontrak has a beta of 2.377, suggesting its more volatile than the S&P 500 by 137.727%.

  • Which is a Better Dividend Stock CTEV or OTRK?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or OTRK?

    Claritev quarterly revenues are $231.3M, which are larger than Ontrak quarterly revenues of $2M. Claritev's net income of -$71.3M is lower than Ontrak's net income of -$6.9M. Notably, Claritev's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.65x versus 0.70x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.65x -- $231.3M -$71.3M
    OTRK
    Ontrak
    0.70x -- $2M -$6.9M
  • Which has Higher Returns CTEV or SPOK?

    Spok Holdings has a net margin of -30.83% compared to Claritev's net margin of 14.32%. Claritev's return on equity of -283.02% beat Spok Holdings's return on equity of 10.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    SPOK
    Spok Holdings
    80.13% $0.25 $151.7M
  • What do Analysts Say About CTEV or SPOK?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -7.03%. On the other hand Spok Holdings has an analysts' consensus of $20.00 which suggests that it could grow by 22.7%. Given that Spok Holdings has higher upside potential than Claritev, analysts believe Spok Holdings is more attractive than Claritev.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    SPOK
    Spok Holdings
    1 0 0
  • Is CTEV or SPOK More Risky?

    Claritev has a beta of 0.515, which suggesting that the stock is 48.504% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.563, suggesting its less volatile than the S&P 500 by 43.737%.

  • Which is a Better Dividend Stock CTEV or SPOK?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.67% to investors and pays a quarterly dividend of $0.31 per share. Claritev pays -- of its earnings as a dividend. Spok Holdings pays out 176.29% of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or SPOK?

    Claritev quarterly revenues are $231.3M, which are larger than Spok Holdings quarterly revenues of $36.3M. Claritev's net income of -$71.3M is lower than Spok Holdings's net income of $5.2M. Notably, Claritev's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 20.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.65x versus 2.41x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.65x -- $231.3M -$71.3M
    SPOK
    Spok Holdings
    2.41x 20.90x $36.3M $5.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Is TTD The Big Winner If Pharma Ads Are Banned?
Is TTD The Big Winner If Pharma Ads Are Banned?

Last week, Senators Bernie Sanders and Angus King introduced a…

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock